Nevertheless, further studies using animal models deficient in Dot1l, Af9, and Edn-1 are required to conclusively demonstrate the role of these players in the spironolactone-mediated improvement of kidney damage in STZ-induced diabetic animals. The gene discussed is MLLT3; the disease is Nephropathy.